Pujadas RX, Viñals RLL

Language: Spanish
References: 25
Page: 239-253
PDF size: 436.48 Kb.

ABSTRACT

Sickle cell anemia or sickle cell disease is one of the most common structural hemoglobinopathies in the world. The clinic is summarized in vascular occlusion and tissue ischemia, hemolytic anemia and vulnerability to infections. Procreation in women with hemoglobinopathies becomes a serious health problem that requires a differentiated and multidisciplinary care. There is no definitive specific treatment for this condition, the existing medical resources can only address the effects and not the cause. The following review aims to offer professionals some aspects related to the pathophysiology, a discussion of the clinical problem, diagnosis and treatment options, which can contribute in reducing morbidity and maternal and perinatal mortality. It is concluded that high level of insight and good diagnosis are necessary for optimum results in pregnant women affected by sickle cell disease.

REFERENCES

1. Rogers DT, Molokie R. Sickle Cell Disease in Pregnancy. Obstet Gynecol Clin North Am. 2010;37(2):223-37.

2. Ferreira A, Henri A, Marguti I, Bechmann I, Beuzard Y, Jeney V, et al. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell. 2011; 145:398-409.

3. Peñaloza RI, Buentello L, Hernández MA, Nieva B, Lisker R, Salamanca F. Frecuencia de la hemoglobina S en cinco poblaciones mexicanas y su importancia en la salud pública. Salud pública Méx. 2008;50(4).

4. Svarch E. Fisiopatología de la drepanocitosis. Rev Cubana Hematol Inmunol Hemoter. 2009;25(1).

5. Kato G, Hebbel R, Streinberg M, Gladwin M. Vasculopathy in Sickle Cell Disease: biology, pathophisiology, genetics, translational medicine and new research direction. Am J Hematol. 2009:618-25.

6. Al Jama FE, Gasem T, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital. Eastern Saudi Arabia. Arch Gynecol Obstet. 2009;280:793-7.

7. Belisário AR, Martins ML, Brito AM, Rodrigues CV, Silva CM, Viana MB. Globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or S_0- thalassemia and their association with clinical and hematological features. Acta Haematol. 2010;124:162-70.

8. Xavier ASG. Experiências reprodutivas de mulheres com anemia falciforme. Salvador. Dissertação [Mestrado em Enfermagem]- Universidade Federal da Bahia; 2011.

9. Booth C, Inusa B, Obaro S.Iinfection in Sickle Cell Disease. Internat J Infect Dis. 2010;14:2-12.

10. Nomura RM, Igai AM, Tosta K, Fonseca GH, Gualandro SF, Zugaib M. Resultados maternos e perinatais em gestac¸ões complicadas por doenc¸as falciformes. Rev Bras Ginecol Obstet. 2010;32:405-11.

11. Al-Farsi SH, Al-Riyami NM, Al-Khabori MK, Al-Hunaini MN. Maternal complications and the association with variables in pregnant women with sickle cell disease. Hemoglobin. 2013;37:219-26.

12. Parrish MR, Morrison JC. Sickle cell crisis and pregnancy. Semin Perinatol. 2013;37:274-9.

13. Martín MR, Duany E, Domínguez M, Alfonso K, Santana ME, Viñales MI. Anemia Falciforme: Conocimientos y percepción actual del riesgo en jóvenes detectados al nacimiento como portadores sanos. Rev Cubana Genet Comunit. 2008;2(3).

14. Santos NS, Chvatal VLS, Varga CRR, Böttcher-Luiz F, Turato ER. Vivências sobre gravidez relatadas por mulheres com anemia falciforme em hospital universitário: um estudo qualitativo. Revista Psicologia e Saúde. 2011;3(2):23-9

15. Monken FV, Barros NN, Valadares PJC, Macedo RSPB, Cruz SG, Cury PS, et al. Situações de urgência na gestante com doença falciforme. Rev méd Minas Gerais. 2010;20(S2):73-7.

16. Martín MR, Lemus MT, Marcheco B. El programa cubano de prevención de Anemia Falciforme. Resultados del periodo 1990-2005. Rev Cubana Genet Comunit. 2008;2(2):59-66.

17. Fernández J, Pérez A, Fragoso M, Rivero R. El diagnóstico temprano de la anemia falciforme: un problema no resuelto en África negra. Rev Cubana Hematol Inmunol Hemoter. 2012;28(2):195-7.

18. González Y, Martín MR. Cumplimiento de principios éticos y normativos en la indicación de la electroforesis de hemoglobina a gestantes. Rev Panorama Cuba y Salud. enero-abril. 2009;4(1):44-53.

19. Taboada N, Gómez M, Algora AE, Noa ME, Arcas G, Noche G, Herrera M. Resultados del Programa de prevención de hemoglobinopatías SS y SC en el periodo 1987-2007 en la provincia Villa Clara, Cuba. Rev Cubana Genet Comunit. 2010;4(1):605-14.

20. Estrada M, Machado G, Estenoz Y. Situación actual del programa de prevención prenatal de sicklemia en el municipio Ciego de Ávila durante 2011. MEDICIEGO. 2012;18(S1)

21. Ngoˆ C, Kayem G, Habibi A, Benachi A, Goffinet F, Galacte´ros F, et al. Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions. Eur J Obstet Gynecol Reprod Biol. 2010;152:138-42.

22. Svarch E. Programa cubano de atención integral al paciente con drepanocitosis. Rev Cubana Hematol Inmunol Hemoter. 2011;27(2):165-7.

23. Royal College of Obstetricians and Gynaecologists Green-top, Guideline. Management of sickle cell disease in pregnancy. RCOG. 2011;61:1-20.

24. Ngo C, Kayem G, A Habibi, Benachi A, Goffinet F, Galactéros E, et al. Embarazo en la enfermedad de células falciformes: resultados maternos y fetales en una población que recibe exanguinotransfusión parcial profilácticos. Eur J Obstet Gynecol Reproductive Biology. 2010.

25. Hernández C, Téllez ML, Espinosa E. Impacto social de la atención integral del embarazo en la drepanocitosis. Scientific Meeting of the International Day of sickle cell disease (sickle cell), saluting the 150th anniversary of the Cuba Academy of Sciences and the International Year of African descent. 2011.